NO154794C - Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrrolidinylsulfamoylbenzosyrederivater. - Google Patents
Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrrolidinylsulfamoylbenzosyrederivater.Info
- Publication number
- NO154794C NO154794C NO801294A NO801294A NO154794C NO 154794 C NO154794 C NO 154794C NO 801294 A NO801294 A NO 801294A NO 801294 A NO801294 A NO 801294A NO 154794 C NO154794 C NO 154794C
- Authority
- NO
- Norway
- Prior art keywords
- pyrrolidinylsulphamoyl
- preparation
- acid derivatives
- therapeutically active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792917997 DE2917997A1 (de) | 1979-05-04 | 1979-05-04 | Substituierte pyrrolidinyl-benzoesaeure- derivate und verfahren zu ihrer herstellung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO801294L NO801294L (no) | 1980-11-05 |
| NO154794B NO154794B (no) | 1986-09-15 |
| NO154794C true NO154794C (no) | 1986-12-29 |
Family
ID=6069917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO801294A NO154794C (no) | 1979-05-04 | 1980-05-02 | Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrrolidinylsulfamoylbenzosyrederivater. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4492710A (no) |
| EP (1) | EP0020941B1 (no) |
| JP (1) | JPS55149251A (no) |
| AR (1) | AR228739A1 (no) |
| AT (1) | ATE3976T1 (no) |
| AU (1) | AU533620B2 (no) |
| CA (1) | CA1152996A (no) |
| DE (2) | DE2917997A1 (no) |
| DK (1) | DK156300C (no) |
| ES (1) | ES8101045A1 (no) |
| FI (1) | FI73413C (no) |
| GR (1) | GR67661B (no) |
| HU (1) | HU181114B (no) |
| IE (1) | IE49779B1 (no) |
| IL (1) | IL59980A (no) |
| NO (1) | NO154794C (no) |
| NZ (1) | NZ193601A (no) |
| PH (1) | PH17465A (no) |
| ZA (1) | ZA802635B (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3727114A1 (de) * | 1987-08-14 | 1989-02-23 | Basf Ag | Verfahren zur herstellung von pyrrolen |
| US11192865B2 (en) * | 2017-08-21 | 2021-12-07 | Vivace Therapeutics, Inc. | Benzosulfonyl compounds |
| CA3084648A1 (en) | 2017-12-06 | 2019-06-13 | Vivace Therapeutics, Inc. | Benzocarbonyl compounds |
| EP3793551A4 (en) | 2018-05-16 | 2022-01-26 | Vivace Therapeutics, Inc. | OXADIAZOLE COMPOUNDS |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3824003A (en) * | 1973-05-07 | 1974-07-16 | Hughes Aircraft Co | Liquid crystal display panel |
| DE2419970C3 (de) * | 1974-04-25 | 1980-06-12 | Hoechst Ag, 6000 Frankfurt | 3-<l-Pyrrolidinyl)-4-phenoxy-5sulfamoylbenzoesäure und Verfahren zu ihrer Herstellung |
| NL7714062A (nl) * | 1976-12-24 | 1978-06-27 | Hoechst Ag | Werkwijze voor de bereiding van pyrrolo-benzoe- zuur-derivaten. |
| DE2658766C2 (de) * | 1976-12-24 | 1986-01-02 | Hoechst Ag, 6230 Frankfurt | 3-N-Pyrrolo-5-sulfamoylbenzoesäure-Derivate und Verfahren zu ihrer Herstellung |
| DE2718494A1 (de) * | 1977-04-26 | 1978-11-09 | Hoechst Ag | Verfahren zur herstellung von pyrrolo-benzoesaeure-derivaten |
| CH628622A5 (de) * | 1976-12-24 | 1982-03-15 | Ciba Geigy Ag | Verfahren zur herstellung von neuen in 4-stellung substituierten 3-sulfamoylbenzoesaeuren. |
-
1979
- 1979-05-04 DE DE19792917997 patent/DE2917997A1/de not_active Withdrawn
-
1980
- 1980-04-28 ES ES490959A patent/ES8101045A1/es not_active Expired
- 1980-04-30 DE DE8080102320T patent/DE3063950D1/de not_active Expired
- 1980-04-30 EP EP80102320A patent/EP0020941B1/de not_active Expired
- 1980-04-30 FI FI801398A patent/FI73413C/fi not_active IP Right Cessation
- 1980-04-30 AT AT80102320T patent/ATE3976T1/de active
- 1980-04-30 HU HU80801073A patent/HU181114B/hu unknown
- 1980-05-01 DK DK193980A patent/DK156300C/da not_active IP Right Cessation
- 1980-05-02 NO NO801294A patent/NO154794C/no unknown
- 1980-05-02 CA CA000351130A patent/CA1152996A/en not_active Expired
- 1980-05-02 GR GR61843A patent/GR67661B/el unknown
- 1980-05-02 IE IE900/80A patent/IE49779B1/en not_active IP Right Cessation
- 1980-05-02 NZ NZ193601A patent/NZ193601A/en unknown
- 1980-05-02 AR AR280883A patent/AR228739A1/es active
- 1980-05-02 PH PH23974A patent/PH17465A/en unknown
- 1980-05-02 ZA ZA00802635A patent/ZA802635B/xx unknown
- 1980-05-02 IL IL59980A patent/IL59980A/xx unknown
- 1980-05-02 AU AU58034/80A patent/AU533620B2/en not_active Expired
- 1980-05-02 JP JP5805080A patent/JPS55149251A/ja active Pending
-
1982
- 1982-09-22 US US06/421,030 patent/US4492710A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FI73413B (fi) | 1987-06-30 |
| IL59980A0 (en) | 1980-07-31 |
| NO154794B (no) | 1986-09-15 |
| NO801294L (no) | 1980-11-05 |
| PH17465A (en) | 1984-08-29 |
| ZA802635B (en) | 1981-05-27 |
| DE2917997A1 (de) | 1980-11-20 |
| AU5803480A (en) | 1980-11-06 |
| AU533620B2 (en) | 1983-12-01 |
| ATE3976T1 (de) | 1983-07-15 |
| FI801398A (fi) | 1980-11-05 |
| GR67661B (no) | 1981-09-02 |
| IE49779B1 (en) | 1985-12-11 |
| AR228739A1 (es) | 1983-04-15 |
| DK156300C (da) | 1989-12-18 |
| IL59980A (en) | 1983-10-31 |
| FI73413C (fi) | 1987-10-09 |
| DK156300B (da) | 1989-07-31 |
| EP0020941B1 (de) | 1983-06-29 |
| IE800900L (en) | 1980-11-04 |
| DE3063950D1 (en) | 1983-08-04 |
| DK193980A (da) | 1980-11-05 |
| ES490959A0 (es) | 1980-12-01 |
| JPS55149251A (en) | 1980-11-20 |
| EP0020941A1 (de) | 1981-01-07 |
| HU181114B (en) | 1983-06-28 |
| ES8101045A1 (es) | 1980-12-01 |
| US4492710A (en) | 1985-01-08 |
| CA1152996A (en) | 1983-08-30 |
| NZ193601A (en) | 1984-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO153177C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater. | |
| NO154346C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater. | |
| NO152899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive glycerolderivater. | |
| NO153136C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater. | |
| NO153927C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-substituerte 4-amino-3-kinolinsyrederivater. | |
| NO151362C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive urinstoffderivater. | |
| NO155774C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater. | |
| NO156611C (no) | Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre. | |
| NO151321C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater | |
| NO152935C (no) | Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater. | |
| NO151463C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater | |
| NO159019C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive 6beta-hydroksyalkylpenicillansyrederivater. | |
| NO151085C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater | |
| NO155055C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater. | |
| NO151588C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater | |
| NO154522C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater. | |
| NO153569C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater. | |
| NO156787C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO153496C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater. | |
| NO148926C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive, nye merkaptoimidazolderivater | |
| NO151500C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater | |
| NO157538C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater. | |
| NO151285C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater | |
| NO148454C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater | |
| NO151660C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater. |